simply creating an open economy will not suffice to stimulate competitiveness if innovation is lacking. This is the major … can be linked to policy changes which foster innovation, but can equally result in stagnation if the policy/practice mix …

This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium …, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It … highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness …

What are the specific characteristics of innovation in pharmaceutical biotechnology? How do biopharmaceutical … innovation systems in OECD countries perform and which policies are suitable to foster performance?. This publication examines … the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan …

that policies can be adapted to stimulate innovation and boost productivity in service sectors, with economy-wide benefits …